In this review, the authors discuss the current knowledge on sex differences in epilepsy and associated co-existing disorders, with emphasis on those aspects most informative for the development of new drug treatments.
Health related quality of life (HRQoL) has become a pivotal outcome parameter after surgery for drug-resistant epilepsy. The aim of the study was to investigate HRQoL and its relationship to seizure outcome, neurological deficits, and anxiety after epilepsy surgery in a specific subpopulation of elderly patients.
The objective of the study was to describe the cognitive, behavioral, psychological, and social functioning of individuals with Dravet syndrome. Click here to read the full abstract.
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy when anti-seizure medications don’t work, according to a study published in the journal Neurology. Read more.
The COVID-19 pandemic has affected people globally, and those with chronic diseases are suffering more in maintaining their mental and physical health. Researchers performed a cross-sectional, case-control study to assess the anxiety level in people with epilepsy compared with the general population.
As concerns regarding neurological manifestations in COVID-19 patients increase, limited data exists on continuous electroencephalography (cEEG) findings in these patients. This article presents a retrospective cohort study of cEEG monitoring in COVID-19 patients to better explore this knowledge gap.
Reports indicate that an early neurological manifestation with seizures should not be ruled out.
Using an arithmetic technique to select the best combination two medications with the highest efficacy, researchers state that there is a positive interaction between two neurosteroids brexanolone and ganaxolone and two antiepileptic medications tiagabine and midazolam.
The 3 papers included in this collection are peer-reviewed studies that systematically assessed EEGs in patients with COVID-19, as of July 26, 2020.
